These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 11582574

  • 1. A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure--function relationships.
    Stavrakoudis A, Bizos G, Eleftheriadis D, Kouki A, Panou-Pomonis E, Sakarellos-Daitsiotis M, Sakarellos C, Tsoukatos D, Tsikaris V.
    Biopolymers; ; 56(1):20-6. PubMed ID: 11582574
    [Abstract] [Full Text] [Related]

  • 2. Discovery and structure--activity relationship studies of a novel and specific peptide motif, Pro-X-X-X-Asp-X, as a platelet fibrinogen receptor antagonist.
    Hayashi Y, Katada J, Sato Y, Igarashi K, Takiguchi Y, Harada T, Muramatsu M, Yasuda E, Uno I.
    Bioorg Med Chem; 1998 Mar; 6(3):355-64. PubMed ID: 9568289
    [Abstract] [Full Text] [Related]

  • 3. Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro.
    Samanen J, Ali F, Romoff T, Calvo R, Sorenson E, Vasko J, Storer B, Berry D, Bennett D, Strohsacker M.
    J Med Chem; 1991 Oct; 34(10):3114-25. PubMed ID: 1920361
    [Abstract] [Full Text] [Related]

  • 4. Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides.
    Müller G, Gurrath M, Kessler H.
    J Comput Aided Mol Des; 1994 Dec; 8(6):709-30. PubMed ID: 7738606
    [Abstract] [Full Text] [Related]

  • 5. Thrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studies.
    Pearson DA, Lister-James, McBride WJ, Wilson DM, Martel LJ, Civitello ER, Dean RT.
    J Med Chem; 1996 Mar 29; 39(7):1372-82. PubMed ID: 8691467
    [Abstract] [Full Text] [Related]

  • 6. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library.
    O'Neil KT, Hoess RH, Jackson SA, Ramachandran NS, Mousa SA, DeGrado WF.
    Proteins; 1992 Dec 29; 14(4):509-15. PubMed ID: 1438188
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Highly constrained cyclic (S,S) -CXaaC- peptides as inhibitors of fibrinogen binding to platelets.
    Kouki A, Mitsios JV, Sakarellos-Daitsiotis M, Sakarellos C, Tselepis AD, Tsikaris V, Tsoukatos DC.
    J Thromb Haemost; 2005 Oct 29; 3(10):2324-30. PubMed ID: 16129021
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cyclic RGD peptide analogues as antiplatelet antithrombotics.
    Barker PL, Bullens S, Bunting S, Burdick DJ, Chan KS, Deisher T, Eigenbrot C, Gadek TR, Gantzos R, Lipari MT.
    J Med Chem; 1992 May 29; 35(11):2040-8. PubMed ID: 1597855
    [Abstract] [Full Text] [Related]

  • 11. Solution structure of a cyclic RGD peptide that inhibits platelet aggregation.
    Jois SD, Tambunan US, Chakrabarti S, Siahaan TJ.
    J Biomol Struct Dyn; 1996 Aug 29; 14(1):1-11. PubMed ID: 8877556
    [Abstract] [Full Text] [Related]

  • 12. Synthesis of cyclic oligopeptides containing an Arg-Gly-Asp (RGD) sequence.
    Sofuku S, Hoshida A, Shimada T, Takada Y, Takakuwa T.
    Chem Pharm Bull (Tokyo); 1999 Dec 29; 47(12):1799-801. PubMed ID: 10748723
    [Abstract] [Full Text] [Related]

  • 13. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
    Sugihara H, Fukushi H, Miyawaki T, Imai Y, Terashita Z, Kawamura M, Fujisawa Y, Kita S.
    J Med Chem; 1998 Feb 12; 41(4):489-502. PubMed ID: 9484499
    [Abstract] [Full Text] [Related]

  • 14. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ, Gunn B, Harms CS, Kline AD, Mullaney JT, Nunes A, Scarborough RM, Arfsten AE, Skelton MA, Um SL, Utterback BG, Jakubowski JA.
    J Med Chem; 1997 Jun 20; 40(13):2085-101. PubMed ID: 9207949
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of fibrinogen binding and surface recruitment of GpIIb/IIIa as dose-dependent effects of the RGD-mimetic MK-852.
    Wittig K, Rothe G, Schmitz G.
    Thromb Haemost; 1998 Mar 20; 79(3):625-30. PubMed ID: 9531053
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of integrin-mediated platelet aggregation, fibrinogen-binding, and interactions with extracellular matrix by nonpeptidic mimetics of Arg-Gly-Asp.
    Varon D, Lider O, Dardik R, Shenkman B, Alon R, Hershkoviz R, Kapustina G, Savion N, Martinowitz U, Greenspoon N.
    Thromb Haemost; 1993 Dec 20; 70(6):1030-6. PubMed ID: 8165596
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
    Andronati SA, Krysko AA, Kabanov VM, Karaseva TL, Kabanova TA.
    Acta Pol Pharm; 2000 Nov 20; 57 Suppl():15-21. PubMed ID: 11293251
    [Abstract] [Full Text] [Related]

  • 19. From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.
    Blackburn BK, Lee A, Baier M, Kohl B, Olivero AG, Matamoros R, Robarge KD, McDowell RS.
    J Med Chem; 1997 Feb 28; 40(5):717-29. PubMed ID: 9057858
    [Abstract] [Full Text] [Related]

  • 20. Design and synthesis of novel cyclic RGD-containing peptides as highly potent and selective integrin alpha IIb beta 3 antagonists.
    Cheng S, Craig WS, Mullen D, Tschopp JF, Dixon D, Pierschbacher MD.
    J Med Chem; 1994 Jan 07; 37(1):1-8. PubMed ID: 7507165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.